Stockhouse.com uses cookies on this site. By continuing to use our service, you agree to our use of cookies. Cookies are used to offer you a better browsing experience and to analyze our traffic. We also use them to share usage information with our partners. See full details.
I Agree
×
Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Privacy Policy | Disclaimer

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Privacy Policy | Disclaimer
Please Try Again {{ error }}

Send my password

Return to Login
SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.

Search Results

Refine Your Search

By Sector

Sort by: Date|Relevance

NervGen Pharma: Proof that NVG-291 works?

It’s arguably a Eureka moment for investors in NervGen Pharma (TSX.V: NGEN) (OTCQB: NGENF). Tantalizing anecdotal “evidence” has just been published that suggests that NervGen’s prospective wonder-drug — NVG-29...
Knox Henderson | 12 days ago |

A potential breakthrough in spinal cord and optic nerve injury treatment

Click Here to Download the Full Report This is third-party provided content issued on behalf of NurExone Biologic Inc., please see full disclaimer here .
Research | December 19, 2024 |

Buzz on the Bullboards: Three engaging TSX stocks with a holiday flavour

TSX this week The TSX has experienced a rocky week, marked by five consecutive sessions of declines. This downturn coincided with the unexpected resignation of Canada’s Finance Minister , Chrystia Freeland, just hours before she was scheduled to pre...
Jonathon Brown | December 19, 2024 |

Critical materials crisis: Diversifying away from China’s monopoly

Author: Jesse Day, Commodity Culture CEO of Leading Edge Materials (TSXV:LEM / OTCQB:LEMIF) Kurt Budge points out China’s dominance in the production and export of critical raw materials such as graphite and rare earths, and why this is a growing...
Research | December 18, 2024 |

Three business reasons companies need to recycle e-waste

Author: Lane Simond . The most common narrative about recycling electronics is that it is better for the environment, but business owners have even more reasons to make sure their outdated technology gets into the hands of a reputable recycler. Three reasons to...
Research | December 18, 2024 |

dynaCERT: Growth Rocket 2025 – Why It’s in the Spotlight

As 2024 draws to a close, it is worth considering new investments for the future. A successful investment in the technology sector requires a sound strategy, thorough research, and an understanding of the ins and outs of the industry. We have summarized key points for in...
Mario Hose | December 16, 2024 |

NurExone Biologic announces important test results

By Brad Sorensen, CFA, Zacks Research. NurExone Biologic (TSXV:NRX; OTCQB:NRXBF) is developing a product known as ExoPTEN that is designed to treat patients with acute spinal cord injuries, while also conducting preclinical tests for other conditions that ExoPTEN m...
Research | December 11, 2024 |

New research report on Nextech3D.AI by H.C. Wainwright & Co.

Click here for the full report . This is sponsored content issued on behalf of Nextech3D.AI Corp., please see full disclaimer here .
Research | December 10, 2024 |

Lithium and copper demand set to grow in 2025

Lithium has already seen a rise in price since the U.S. presidential election and analysts predict a huge demand for copper . Grid Battery Metals (TSXV:CELL) has lithium projects in Nevada and a Copper in British Columbia and the company’s CEO, Tim Fer...
Research | December 6, 2024 |

Lode Gold: A compelling investment opportunity for gold enthusiasts

Lode Gold (TSXV:LOD) has had a year of growth achieving one milestone after another. Despite facing a challenging market, the company has successfully raised $6M since March 2024. Now, investors have the chance to capitalize on a unique opportunity by investing in Lode ...
Research | December 4, 2024 |
1 2 3 4 5 6 7 8 9 10 ...